Adlai Nortye (ANL) Current Taxes (2023 - 2025)

Adlai Nortye (ANL) reported Current Taxes of $18000.0 for Q4 2025, down 76.0% year-over-year from $75000.0 in Q4 2024, and down 76.0% on a QoQ basis from $75000.0 in Q4 2024.

Adlai Nortye (ANL) has 3 years of Current Taxes data on file, last reported at $18000.0 in Q4 2025.

  • Quarterly Current Taxes fell 76.0% year-over-year to $18000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18000.0 (down 76.0% YoY) and the FY2025 annual result came in at $18000.0, down 76.0% from the prior year.
  • Current Taxes declined to $18000.0 in Q4 2025 per ANL's latest filing, from $75000.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $130000.0 in Q4 2023 and bottomed at $18000.0 in Q4 2025.
  • The 3-year median for Current Taxes is $75000.0 (2024), against an average of $74333.3.
  • The widest annual swing landed in 2024, when Current Taxes sank 42.31%; it then sank 76.0% in 2025.
  • Tracing ANL's Current Taxes over 3 years: stood at $130000.0 in 2023, then slumped by 42.31% to $75000.0 in 2024, then slumped by 76.0% to $18000.0 in 2025.
  • Per Business Quant, the three latest ANL Current Taxes figures stand at $18000.0 (Q4 2025), $75000.0 (Q4 2024), and $130000.0 (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - -
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - 10,460.56
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn 19.20 Mn
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn -
8 Evaxion A 65.44 Bn 65.42 Bn - -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn -
10 Adlai Nortye 23,840.00 -8.03 Mn - 18,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 18,000.00
Dec 31, 2024 75,000.00
Dec 31, 2023 130,000.00